Merck is undergoing a strategic restructuring, resulting in immediate job cuts in administration, sales, and research as part of a plan to save $3 billion by 2027.

Merck’s stock is falling after a rare revenue miss, and the announcement of a $3 billion cost-cutting plan that will include layoffs.

Merck and Co. is slashing $3 billion from its annual spending as it braces for off-brand competition to its cancer drug Keytruda, the best-selling medicine in the world.

MSD has said it will cut $3 billion off its annual costs by the end of 2027 as it prepares for the end of patent protection ...

Posted 2024-01-22T19:47:52Z - Updated 2024-01-22T20:50:07Z By David Arkin This article was written for our sponsor, North Carolina Biotechnology Center ...

The drugmaker Merck announced it has opened a $1 billion vaccine manufacturing facility in north Durham, a 225,000-square-foot addition to the company’s existing campus off Old Oxford Road.

Merck’s Maurice R. Hilleman Center for Vaccine Manufacturing photographed on Friday, Apr. 2, 2021, in Durham, N.C. ·Raleigh News and Observer·Casey Toth/ctoth@newsobserver.com Brian Gordon ...

Merck sign outside its plant in Durham (WRAL photo) by Jamie Crockett, NC A&T via N.C. Biotech Center — June 12, 2023 .

Merck & Co., Inc. At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world ...

DURHAM – North Carolina’s unemployment rate is still hovering near 10 percent, but don’t tell that to pharmaceutical giant Merck & Co. By the end of this year, Merck will grow its Durham ...